Skip to main content
. 2007 Apr;3(2):219–235. doi: 10.2147/nedt.2007.3.2.219

Figure 5.

Figure 5

Mean change in Scale for the Assessment of Positive/Negative Symptoms (SANS) scores from baseline to week 12 following treatment with quetiapine or risperidone.

**p < 0.01 vs baseline, ***p < 0.001 vs, baseline (paired t-tests), p = 0.065 vs risperidone (unpaired t-test).